MedPath

0.05 mg Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy

Phase 4
Conditions
Pain
Interventions
Registration Number
NCT01080911
Lead Sponsor
Mahidol University
Brief Summary

This study aims to compare the effect of spinal morphine between the dose 0.05 mg and 0.1 mg on the amount of morphine during the first 24 hours postoperative.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
72
Inclusion Criteria
  • Female ASA 1-3
  • Undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty
  • Can operate PCA device
Exclusion Criteria
  • History of allergy to the study drugs
  • History of bleeding tendency
  • History of infection at the back
  • Patient refuse to have spinal anesthesia
  • History of CAD or CVD

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
spinal morphine 0.05 mgMorphinespinal morphine 0.05 mg plus 0.5% heavy marcaine 3.5 ml
spinal morphine 0.1 mgMorphinespinal morphine 0.1 mg plus 0.5% heavy marcaine 3.5 ml
Primary Outcome Measures
NameTimeMethod
the amount of 24 hours morphine24 hour
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine, Siriraj Hospital, mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath